semaglutide cancer cases New Research Challenges Fears of Semaglutide-Linked Thyroid Risk Frontiers | GLP-1 receptor agonist

MoA: Visualization, Data curation, Methodology, Validation, Investigation, Conceptualization, Project administration, Software, Funding acquisition, Writing original draft, Supervision, Formal analysis, Resources, Writing review & editing

Not catastrophic, but worth knowing, especially if your last dose from a vial seems to come up short

However, persistent severe vomiting lasting more than 24 hours, inability to keep food or fluids down, or signs of dehydration warrant immediate contact with your provider

One of the biggest problems with the term microdosing, as it pertains to GLP-1s, Levy says, is that its vague, and theres no consensus on what its referring to